Energy and Pharma Drive October Surge in US Mergers and Acquisitions Market

October has seen a surge of activity in the United States Mergers and Acquisitions market, making it the busiest month since June 2019. Several industries, notably energy and pharmaceuticals, have been key drivers in this uptick in deal-making activity.

Despite the escalating geopolitical uncertainty and challenges from the Israel-Hamas war, major deals continue to push through successfully. For instance, Chevron Corp. announced a $53 billion acquisition of Hess Corp., reinforcing their commitment to the fossil fuel industry. Similarly, Vista Equity Partners signed an agreement to acquire software company EngageSmart Inc. in a $4 billion deal.

By October’s end, there were over $139 billion in takeovers of publicly traded U.S. companies according to data compiled by Bloomberg. This is approximately three times the volume seen during the same period last year and marks the highest for any single month since June 2019. The last two months have seen four out of the five global largest M&A deals this year.

Geographical borders have not limited activity either. Swiss pharmaceutical company Roche Holding AG, announced it will pay $7.1 billion for an inflammatory bowel disease treatment. Furthermore, Mukesh Ambani’s Reliance Industries Ltd. is reportedly nearing a deal for Walt Disney Co.’s Indian operations.

The sector also saw Microsoft Corp. completing a nearly two-year regulatory battle to finalize its $69 billion purchase of Activision Blizzard Inc. This successful completion could potentially embolden other companies to take on antitrust authorities in their pursuits.

The energy industry received a major boost with Exxon Mobil Corp.’s $60 billion takeover of Pioneer Natural Resources Co. and possible future deals are in discussion, including Devon Energy Corp. eyeing major acquisition targets such as Marathon Oil Corp.

Pharmaceuticals are also an active piece of the puzzle, with Bristol Myers Squibb Co. agreeing to buy biotech firm Mirati Therapeutics Inc. to replenish its pipeline. Amid the flurry of transactions, Goldman Sachs Group Inc. has risen as the most active M&A advisor globally this year with a 26% market share, followed by Morgan Stanley at 22% and JPMorgan Chase & Co. at 21%.